Antioxidants in the Fight Against Atherosclerosis: Is This a Dead End?

Treatment of alcoholic hepatitis: is this a “dead-end”?

Alcoholic hepatitis (AH) is a clinical syndrome characterized by jaundice and liver failure that develops in subjects with chronic and active alcohol abuse [1]. The shortterm mortality in patients with severe disease, as defined by the Maddrey’s discriminant function, exceeds 30% [2]. Up to now, only two drugs, prednisolone and pentoxifylline, have shown some efficacy for the treatment of this ...

The Jurisprudential Foundations of the Fight against Terrorism and Iran's Efforts in this Regard

Terrorism is an act whose nature and outcome is violence and fear. Regardless of the different forms of the realization of this act in the past, it has taken new forms in the contemporary era due to the advancement of sciences and technologies. To face this phenomenon, then, it is necessary to foresee and apply appropriate and favorable measures. As a victim of internal and external terrorism, ...

Flavonoids: Antioxidants Against Atherosclerosis

Oxidative stress results from an imbalance between excessive formation of reactive oxygen species (ROS) and/or reactive nitrogen species and limited antioxidant defences. Endothelium and nitric oxide (NO) are key regulators of vascular health. NO bioavailability is modulated by ROS that degrade NO, uncouple NO synthase, and inhibit synthesis. Cardiovascular risk conditions contribute to oxidati...

Making things stick in the fight against atherosclerosis.

Industry in the fight against COVID-19 crisis